You did everything the same. Same meals. Same movement. Same routine. And somewhere around 40, it stopped working. The weight crept on. The energy disappeared. Sleep fell apart. Your doctor said your bloods were fine.
Then someone mentioned Ozempic. If you're a woman in perimenopause considering a GLP-1 medication — or already on one — there are things you need to know that most prescribers aren't talking about.
Why perimenopause makes weight loss harder
This part isn't in your head. The hormonal shifts that begin in your late 30s and accelerate through your 40s fundamentally change how your body stores and processes fat.
Declining oestrogen
Reduces insulin sensitivity — your body becomes less efficient at using glucose for energy and more likely to store it as fat
Progesterone fluctuations
Affect water retention, appetite, and sleep quality — often simultaneously
Elevated cortisol
Tends to run higher during perimenopause, driving fat storage specifically around the middle
Muscle mass decline
Oestrogen was helping protect lean mass. As it falls, metabolic rate drops year on year
Research shows women gain an average of about half a kilogram per year during the menopausal transition — and for many women it's significantly more than that. This isn't a failure of discipline. It's a shift in biology.
GLP-1 medications work for perimenopausal women
The good news is that GLP-1 medications appear to be just as effective for women in perimenopause and menopause as they are for younger women. A post hoc analysis of the SURMOUNT trials (studying tirzepatide) found that women achieved approximately 20% weight reduction regardless of whether they were premenopausal, perimenopausal, or postmenopausal.
RAND data from 2025 showed that women aged 50–64 had the highest GLP-1 use overall, with 20% reporting current or past use. Women aged 30–49 were more than twice as likely as men of similar age to be using these medications.
Perimenopausal women are the largest demographic using GLP-1s, yet they've been largely overlooked in the research. The medications work. The question is whether they're being used in a way that accounts for what's actually happening hormonally.
“The medication works. The question is whether it's being used in a way that accounts for what's actually happening hormonally — because in perimenopause, the stakes around muscle, bone, and sleep are higher.”
The risks that hit harder after 40
Muscle loss is a bigger deal in perimenopause
Muscle loss on GLP-1 medications is a concern for everyone, but for women over 40 it's compounded by the fact that you're already losing muscle naturally. Oestrogen plays a protective role in maintaining lean mass. As it declines, holding on to muscle becomes harder. Add a GLP-1 medication that suppresses appetite — making it difficult to eat enough protein — and you have a recipe for accelerated muscle loss.
Research suggests that up to 40% of weight lost on GLP-1 medications can be lean mass rather than fat if protein intake and resistance training aren't prioritised. For a perimenopausal woman, this isn't just a body composition issue. It affects bone density, metabolic rate, strength, balance, and long-term independence.
Resistance training and adequate protein aren't optional extras in this context. They're essential.
Bone density needs attention
Oestrogen decline already increases osteoporosis risk. Rapid weight loss — from any cause — can accelerate bone mineral density loss. If you're on a GLP-1 and losing weight quickly without weight-bearing exercise, your bones may be paying a price that won't show up until years later.
This is another reason resistance training matters so much. It's not just about muscle. Weight-bearing exercise directly stimulates bone density maintenance — and in perimenopause, that stimulus becomes more important, not less.
Sleep disruption compounds everything
Poor sleep is one of the hallmarks of perimenopause: night sweats, racing thoughts, waking at 3am. And poor sleep directly undermines everything a GLP-1 is trying to do. Even one night of poor sleep measurably increases ghrelin (the hunger hormone), decreases leptin (the fullness hormone), increases insulin resistance, and drives cortisol higher — all of which are primary drivers of food noise.
If your sleep isn't being addressed alongside the medication, you're fighting the weight battle with one hand tied behind your back. Sleep isn't a nice-to-have in your GLP-1 plan. It's foundational — and in perimenopause, it's often the hardest piece to fix without direct support.
GI side effects can be more intense
The most common GLP-1 side effects — nausea, constipation, bloating, reduced appetite — can feel more intense during perimenopause. Hormonal fluctuations already affect gut motility and digestive sensitivity. Layering a medication that slows gastric emptying on top of that can amplify discomfort.
Starting at the lowest dose and escalating slowly is even more important for this group. So is eating small, protein-rich meals rather than trying to force larger portions when nausea is present. The goal is to keep protein intake consistent even when appetite is suppressed — not to push through discomfort.
What a good GLP-1 plan looks like for women over 40
01
Protein becomes your highest priority
Every meal needs to be protein-forward. When your appetite is suppressed, every bite has to count. Aim for 1.2 to 1.6 grams of protein per kilogram of body weight daily. This protects muscle, supports bone health, stabilises blood sugar, and helps with satiety when the medication's appetite suppression starts to fluctuate — which it often does with hormonal cycling.
02
Resistance training two to three times per week
Not cardio. Not yoga alone. Progressive resistance training that challenges your muscles enough to maintain and build lean mass. This is the single most important exercise you can do for metabolic health, bone density, and long-term function in perimenopause. It's non-negotiable whether you're on a GLP-1 or not.
03
Address sleep as a clinical priority
Track your sleep. If you're consistently getting fewer than six hours or waking multiple times, this needs attention before anything else can work optimally. Strategies vary: temperature management, light exposure timing, stress management, and in some cases discussing HRT with your doctor if night sweats are the primary disruptor.
04
Monitor body composition, not just weight
The scales might show the number you want, but if a significant portion of what you've lost is muscle, your metabolic health hasn't actually improved. A DEXA scan gives you the full picture: fat mass, lean mass, bone density. This is the measurement that actually matters.
05
Have an exit plan
GLP-1 medications aren't necessarily forever. The best time to think about what happens when you stop is while you're still on them. Are the foundations solid enough to hold without the medication? Is your relationship with food stable enough? Are your habits genuinely embedded, not just supported by suppressed appetite?
The HRT question
Many perimenopausal women are on HRT, considering it, or have been told it's not appropriate for them. The relationship between HRT and GLP-1 medications is an area where the evidence is still developing, but what we know is this: oestrogen replacement helps preserve muscle mass and bone density, improves insulin sensitivity, and supports sleep — all of which directly support better outcomes on a GLP-1.
If you're on a GLP-1 and not on HRT, it's worth having a conversation with your GP about whether it's appropriate for you. The two aren't mutually exclusive — and for many women, addressing the hormonal environment alongside the medication produces significantly better results than either approach alone.
The bigger picture
GLP-1 medications can be a powerful tool for women navigating perimenopause. They work. The evidence supports that. But perimenopause isn't just a weight problem. It's a metabolic, hormonal, and behavioural shift that affects every system in your body.
A prescription alone doesn't address the sleep disruption, the muscle loss, the stress, the changing relationship with food, or the metabolic foundations that determine whether the results last. That work still needs to happen. The medication just makes it easier to do.
If you're considering a GLP-1, already on one, or thinking about coming off, the question worth asking isn't just “is this working?” It's “what am I building underneath it?”
The question worth asking isn't just “is this working?” It's “what am I building underneath it?”
Common questions
Do GLP-1 medications work for women in perimenopause?
Yes. A post hoc analysis of the SURMOUNT trials found that women achieved approximately 20% weight reduction regardless of menopausal status. The medications are effective — but the hormonal context means the risks around muscle loss, bone density, and sleep disruption need more active management than in younger women.
Why is weight loss harder in perimenopause?
Declining oestrogen reduces insulin sensitivity, making the body more likely to store glucose as fat. Progesterone fluctuations affect appetite and sleep. Cortisol tends to run higher, driving abdominal fat storage. And the gradual loss of muscle mass that oestrogen was protecting means metabolic rate drops year on year. This is biology, not discipline.
Can I take Ozempic and HRT at the same time?
Yes — they're not mutually exclusive. HRT helps preserve muscle mass and bone density, improves insulin sensitivity, and supports sleep, all of which directly support better outcomes on a GLP-1. If you're on a GLP-1 and not on HRT, it's worth discussing with your GP whether it's appropriate for your situation.
What should perimenopausal women prioritise on a GLP-1?
Protein intake (at least 1.2–1.6g per kg of body weight daily), progressive resistance training two to three times per week, sleep support, slow dose escalation to manage GI side effects, and building an exit strategy from the start. The hormonal environment in perimenopause makes all of these more important, not less.
On a specific medication?
On Ozempic?
Ozempic and Perimenopause
What women over 40 on semaglutide specifically need to know.
On Wegovy?
Wegovy and Perimenopause
How the 2.4mg dose changes the risk profile for women over 40.
On Mounjaro?
Mounjaro and Perimenopause
How tirzepatide's dual mechanism changes the risk profile for women over 40.
On any GLP-1?
GLP-1 and Muscle Loss: What You Need to Know
How to protect lean mass while the medication is working — regardless of which one you're on.
Thinking about stopping?
On Ozempic?
How to come off Ozempic without regaining weight
The taper approach and what to build first — with the perimenopause context in mind.
On Wegovy?
How to come off Wegovy without regaining weight
Why the higher dose makes the exit strategy even more important for women in perimenopause.
On Mounjaro?
How to come off Mounjaro without regaining weight
Tirzepatide's potency makes the foundations — and the taper — especially critical in perimenopause.
Explore further
On a GLP-1 in perimenopause — or thinking about it?
The hormonal context of perimenopause changes what you need to do alongside the medication. I work with women in midlife at every stage of the GLP-1 journey — and I understand both the metabolic and hormonal picture. Book a free 30-minute consultation and let's talk through where you are.
Book a free consultation
